DE69327247T2 - Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung - Google Patents

Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung

Info

Publication number
DE69327247T2
DE69327247T2 DE69327247T DE69327247T DE69327247T2 DE 69327247 T2 DE69327247 T2 DE 69327247T2 DE 69327247 T DE69327247 T DE 69327247T DE 69327247 T DE69327247 T DE 69327247T DE 69327247 T2 DE69327247 T2 DE 69327247T2
Authority
DE
Germany
Prior art keywords
active substance
physiologically active
pharmaceutically acceptable
acceptable salt
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327247T
Other languages
German (de)
English (en)
Other versions
DE69327247D1 (de
Inventor
Takashi Harada
Masayuki Kitagawa
Tomio Morino
Ayako Nakatani
Seiichi Saito
Masaya Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Application granted granted Critical
Publication of DE69327247D1 publication Critical patent/DE69327247D1/de
Publication of DE69327247T2 publication Critical patent/DE69327247T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69327247T 1992-09-09 1993-09-08 Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung Expired - Fee Related DE69327247T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26564692 1992-09-09
PCT/JP1993/001276 WO1994005679A1 (fr) 1992-09-09 1993-09-08 Nouvelle substance physiologiquement active appelee nk175203, son procede de production et son utilisation pharmaceutique

Publications (2)

Publication Number Publication Date
DE69327247D1 DE69327247D1 (de) 2000-01-13
DE69327247T2 true DE69327247T2 (de) 2000-05-18

Family

ID=17420032

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327247T Expired - Fee Related DE69327247T2 (de) 1992-09-09 1993-09-08 Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung

Country Status (5)

Country Link
US (1) US5505944A (https=)
EP (1) EP0659759B1 (https=)
CA (1) CA2142453A1 (https=)
DE (1) DE69327247T2 (https=)
WO (1) WO1994005679A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0760242A4 (en) * 1994-05-23 2001-04-04 Nippon Kayaku Kk NEURON DIFFERENTIATION ACCELERATOR
CA2246054A1 (en) * 1996-01-31 1997-08-07 Nippon Kayaku Kabushiki Kaisha 2,3-disubstituted cyclopentanone derivatives, process for producing the same, and medicinal use thereof
WO1998048029A1 (fr) * 1997-04-24 1998-10-29 Nippon Kayaku Kabushiki Kaisha Procede de preparation de derives d'acide cyclopentanecarboxylique

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840934A (en) * 1983-01-25 1989-06-20 Eleanor Roosevelt Institute For Cancer Research, Inc. Therapeutic method using T cell growth factor
US4822735A (en) * 1983-01-25 1989-04-18 Eleanor Roosevelt Institute For Cancer Research, Inc. T cell growth factor and method of making same
US4623622A (en) * 1983-01-25 1986-11-18 Eleanor Roosevelt Institute For Cancer Research, Inc. T-cell growth factor and method of making same
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
JPS61166710A (ja) * 1985-01-17 1986-07-28 Katsusato Fujiyoshi スベリ止め部材
ATE65798T1 (de) * 1985-02-08 1991-08-15 Chugai Pharmaceutical Co Ltd Menschlicher granuloxcyt-koloniestimulierungsfaktor.
JPH0657152B2 (ja) * 1985-09-17 1994-08-03 中外製薬株式会社 Ｃｓｆ遺伝子類
US5162317A (en) * 1988-05-12 1992-11-10 Esai Co., Ltd. Pyridinium salt and pharmacological composition containing the same
US5035878A (en) * 1988-09-12 1991-07-30 University Of Rochester Use of dithiocarbamates to counteract myelosuppression
JP2846331B2 (ja) * 1989-03-01 1999-01-13 電気化学工業株式会社 骨髄細胞分化増殖因子、その産生細胞及びその製法
US5223605A (en) * 1990-04-16 1993-06-29 Immunex Corporation Interleukin-4 binding protein-γ

Also Published As

Publication number Publication date
EP0659759A4 (https=) 1995-07-05
EP0659759A1 (en) 1995-06-28
WO1994005679A1 (fr) 1994-03-17
DE69327247D1 (de) 2000-01-13
US5505944A (en) 1996-04-09
CA2142453A1 (en) 1994-03-17
EP0659759B1 (en) 1999-12-08

Similar Documents

Publication Publication Date Title
DE3783588T2 (de) Neue verbindungen dc-88a und dc-89a1 und deren herstellungsverfahren.
DE2532568A1 (de) Aclacinomycine a und b und verfahren zu ihrer herstellung
DE69011913T2 (de) Phthalinidderivat, pharmazeutische Zubereitung und Verwendung.
DE68902670T2 (de) Ks-506 verbindungen und verfahren zu deren herstellung.
DE69222150T2 (de) Prozess zur produktion von cyclosporin-a und/oder c
DE69327247T2 (de) Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung
DE3888587T2 (de) AB-006-Antibiotika und Verfahren zu deren Herstellung.
DE69021716T2 (de) Verfahren zur herstellung von vancomycin.
DE69114252T2 (de) Reveromycin-a, herstellung und verwendung als antitumormittel sowie als fungizid.
DE2715255B2 (de) Anthracyclinglykoside MA 144-M1 und MA 144-M2 und deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE3785868T2 (de) Tierwachstum foerdernde mittel.
DE69903465T2 (de) Vancoresmycin, verfahren zu dessen herstellung und dessen anwendung als arzneimittel
DE2455683A1 (de) Verfahren zur herstellung von deacetoxycephalosporin c
EP0304400B1 (de) Phenanthridinderivate, Verfahren zu ihrer Herstellung und Mittel zur Ausführung des Verfahrens
DE69218067T2 (de) Verfahren zur Herstellung von 3-deacylierten Derivaten eines 16-gliedrigen Macrolid-Antibiotikums, hierfür verwendeter Mikroorganismus, sowie neues Macrolid-Antibiotikum
DE69009923T2 (de) Antifungales Antibiotikum und seine Herstellung und Verwendung.
DE69129924T2 (de) Antibiotikum und Verfahren zu seiner Herstellung
DE69106577T2 (de) UCF1 Verbindungen, deren Derivate und Verfahren zu ihrer Herstellung.
DE3881821T2 (de) Verbindung WF 2015 A und B, deren Herstellung und Verwendung.
DE69005899T2 (de) Karzinostatisches oder antitumorales Antibiotikum, Conagenin, seine Herstellung und seine Verwendungen.
DE69111119T2 (de) Durch Fermentation hergestellte Polysaccharide.
DE3882654T2 (de) Enzymhemmer und Methode zu dessen Herstellung.
DE69206858T2 (de) Verbindung UCA1064-B
DE69130643T2 (de) Tan-1251-verbindung, ihre derivate, herstellung und verwendung
DE60101313T2 (de) Pluraflavine und derivate davon, verfahren zu ihrer herstellung und verwendung derselben

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee